Search Within

Kamal Nand Menghrajani

Formats
  1. Meeting Abstract (24)
  2. Journal Article (17)
  3. Research Letter (2)
Groups
  1. Department of Medicine (43)
  2. Hematologic Malignancies, Division of (43)
  3. Weinberg Fellows (43)
  4. Center for Hematologic Malignancies (42)
  5. Adult Leukemia (41)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (30)

More Groups

People
  1. Ross Levine (27)
  2. Martin Tallman (23)
  3. Christopher Famulare (21)
  4. Jacob Glass (18)
  5. Sean Devlin (17)
  6. Mikhail Roshal (14)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (7)
  4. 2022 (2)
  5. 2021 (5)
  6. 2020 (11)

More Years

Publications
  1. Blood (21)
  2. Blood Advances (5)
  3. American Journal of Hematology (2)
  4. Haematologica (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Cell Stem Cell (1)

More Publications

Publishers
  1. American Society of Hematology (26)
  2. Nature Publishing Group (4)
  3. Cell Press (2)
  4. Elsevier Inc. (2)
  5. Ferrata Storti Foundation (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acute leukemia with lineage infidelity: Mixed phenotype AML exhibits a distinct immunophenotype with clinical features overlapping mixed phenotype acute leukemia
    Meeting Abstract

    Kresch, M. P.; Xiao, W.; Menghrajani, K.; Famulare, C.; Patel, M. A.; Baik, J.; Roshal, M.; Levine, R. L.; Tallman, M. S.; Glass, J. L.
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Meeting Abstract

    Bernard, E.; Nannya, Y.; Yoshizato, T.; Hasserjian, R. P.; Saiki, R.; Shiozawa, Y.; Devlin, S. M.; Tuechler, H.; Sarian, A.; Malcovati, L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Choosing for whom to recommend allogeneic transplantation for acute myeloid leukemia in CR1: A continued, complicated conversation
    Journal Article

    Menghrajani, K. N.; Tallman, M. S.
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms
    Journal Article

    Rampal, R. K.; Mascarenhas, J. O.; Kosiorek, H. E.; Price, L.; Berenzon, D.; Hexner, E.; Abboud, C. N.; Kremyanskaya, M.; Singer Weinberg, R.; Salama, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • New therapeutic strategies for high-risk acute myeloid leukemia
    Journal Article

    Menghrajani, K.; Tallman, M. S.
    Current Opinion in Hematology (2018)

    Fulltext@MSK | Save